Table 3.
Pooled estimates of flaxseed oil effects on antioxidant system function within different subgroups.
Variables | No. of studies | WMD or SMD (95% CI) | P value | I2 (%) | P heterogeneity |
---|---|---|---|---|---|
MDA | |||||
Total | 8 | −0.52 (−0.89, −0.15) | 0.006 | 71.3 | <0.001 |
FL dosage (mg) | |||||
≤2000 | 4 | −0.84 (−1.11, −0.56) | <0.001 | 68.0 | 0.025 |
>2000 | 4 | −0.14 (−0.43, 0.14) | 0.311 | — | 0.398 |
| |||||
Sample size | |||||
≤26 | 4 | −0.53 (−0.83, −0.22) | <0.001 | 82.7 | <0.001 |
>26 | 4 | −0.48 (−0.74, −0.23) | <0.001 | 57.3 | 0.071 |
| |||||
Intervention duration (week) | |||||
≤8 | 4 | −0.53 (−0.83, −0.22) | <0.001 | 82.7 | <0.001 |
>8 | 4 | −0.48 (−0.74, −0.23) | <0.001 | 57.3 | 0.071 |
| |||||
Mean age (years) | |||||
≤48 | 4 | −0.43 (−0.71, −0.15) | 0.002 | 84.6 | <0.001 |
>48 | 4 | −0.57 (−0.84, −0.29) | <0.001 | 32.6 | 0.217 |
| |||||
Type of flaxseed | |||||
Flaxseed oil | 5 | −0.33 (−0.58, −0.08) | 0.010 | 62.3 | 0.031 |
Omega-3 fatty acid from flaxseed oil | 3 | −0.78 (−1.10, −0.46) | <0.001 | 77.5 | 0.012 |
| |||||
GSH | |||||
Total | 4 | 0.45 (−0.12, 1.01) | 0.122 | 77.9 | 0.004 |
Mean age (years) | |||||
≤48 | 1 | 1.19 (0.59, 1.79) | <0.001 | — | — |
>48 | 3 | 0.21 (−0.08, 0.51) | 0.159 | 62.3 | 0.070 |
| |||||
Type of flaxseed | |||||
Flaxseed oil | 1 | 0.34 (−0.17, 0.85) | 0.187 | — | — |
Omega-3 fatty acid from flaxseed oil | 3 | 0.43 (0.12, 0.74) | 0.007 | 85.2 | 0.001 |
| |||||
TAC | |||||
Total | 5 | 82.84 (19.80, 145.87) | 0.010 | 92.7 | <0.001 |
Mean age (years) | |||||
≤48 | 2 | −0.02 (−0.03, −0.01) | 0.003 | 66.0 | 0.086 |
>48 | 3 | 143.4(101.22, 185.61) | <0.001 | 72.7 | 0.026 |
| |||||
Type of flaxseed | |||||
Flaxseed oil | 2 | −0.02 (−0.03, −0.01) | <0.001 | 66.0 | 0.003 |
Omega-3 fatty acid from flaxseed oil | 3 | 46.88 (19.85, 73.92) | 0.023 | 51.8 | <0.001 |
MDA: malondialdehyde; GSH: glutathione; TAC: total antioxidant capacity; SMD: standardized mean difference; WMD: weighted mean difference; CI: confidence interval.